Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

Ruiguang Zhang,1 Yan Li,2 Xiu Nie,2 Xiaorong Dong,1 Gang Wu1 1Cancer Center, 2Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China Background: Epidermal growth factor receptor (EGFR) mutations in...

Full description

Bibliographic Details
Main Authors: Zhang R, Li Y, Nie X, Dong X, Wu G
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:OncoTargets and Therapy
Subjects:
lung adenocarcinoma
epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)
prognosis
markers
Online Access:https://www.dovepress.com/prognostic-implications-of-immunohistochemistry-markers-for-egfr-tki-t-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/prognostic-implications-of-immunohistochemistry-markers-for-egfr-tki-t-peer-reviewed-article-OTT

Similar Items